Mitralign

Transcatheter annuloplasty system for tricuspid and mitral regurgitation

Mitralign Inc. is the valve repair company with the only direct transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. It has developed an innovative therapy for the reduction of functional mitral regurgitation (FMR), a life-threatening cardiac condition affecting four million people in the US alone. Its unique system provides a new solution for interventional cardiologists and their patients.